Mission San Jose y San Miguel de Aguayo [1720]
Mission San Jose was the last stop on our long weekend tour of the sights of Austin and San Antonio. San Jose is one of the five Missions built by the Spaniards in the eighteenth century [the most famous being the Alamo]. It’s now a beautiful National Park and a great place to ponder things, like the trial we’re attending in Austin. In the courtroom, it’s easy to miss the forest for the trees – so many documents and interesting things going on at once. Sitting there yesterday afternoon, I could think about the case – remember how it fits in the bigger story. In the courtroom where I am now, I can feel the big picture evaporating. We’re early again, watching the principals march in with their briefcases, followed by staff pulling dollies with boxes [and boxes].
The morning began with Tiffany Moage, San Antonio Sales Rep whose Call-Notes were reviewed in Mr. Friede’s testimony and her District Manager, Shane Scott. We saw Call Note after Call Note where she called on Child and Adolescent Psychiatrists, documenting her detailing M-Tabs [dissolving Risperdal Tablets] for use in kids. We heard about a "Back to School" campaign – Concerta and Risperdal, for kids.We heard the same from her boss. Her boss seemed bothered by the references to off-label promotion. But both contended there was no off-label promotion. Mr. Jacks, the plaintiff’s lawyer didn’t confront the obvious disconnect. He just showed it [over and over]. Now we’re on luch break, after hearing Dr. Bruce Perry. We’re in mid testimony, but the topic is "ghost-writing," "guest-authorship," and "seeding." I think I’ll summarize things after he finishes [and lunch].
Excellent coverage Doc.
biomarker, personal medicine, quintiles, academic-private partnerships
“Quintiles is expanding its reach in personalized medicine, forming a new company that will conduct biomarker research and development in cancer.
The company, Oxford Cancer Biomarkers, is based on technology developed at the University of Oxford.”…..
“Oxford Cancer Biomarkers will develop the biomarkers at its laboratories in Oxford. Those biomarkers will be tranfserred to Quintiles’ facility in Edinburg, Scotland for commercial production.”
http://www.medcitynews.com/2012/01/quintiles-forms-biomarker-firm-for-personalized-medicine-cancer-approach/